Table 3. Mean (SE) dose at baseline and maintenance phase of vitamin D/phosphate binders

AMG 073Placebo
Mean (SE)nMean (SE)n
a Values were not different between groups (P > 0.05).
Calcitriol injection dose (μg/wk)
    baseline4.3 ± 0.6144.5 ± 0.617
    maintenance phasea3.4 ± 0.5243.2 ± 0.520
Paricalcitol injection dose (μg/wk)
    baseline22.1 ± 5.9821.0 ± 5.25
    maintenance phasea15.6 ± 4.21214.0 ± 3.89
Elemental calcium dose from calcium-containing phosphate binders (mg/d)
    baseline1903 ± 193271630 ± 13827
    maintenance phasea1901 ± 163261924 ± 30726
Sevelamer hydrochloride dose (mg/d)
    baseline5094 ± 1014143777 ± 10358
    maintenance phasea4983 ± 507153930 ± 6186